111 related articles for article (PubMed ID: 11552025)
1. Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy.
Peltola J; Ukkonen M; Moilanen E; Elovaara I
Neurology; 2001 Sep; 57(5):895-6. PubMed ID: 11552025
[TBL] [Abstract][Full Text] [Related]
2. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
Yuceyar N; Taşkiran D; Sağduyu A
Clin Neurol Neurosurg; 2001 Dec; 103(4):206-11. PubMed ID: 11714562
[TBL] [Abstract][Full Text] [Related]
3. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
[TBL] [Abstract][Full Text] [Related]
4. The role of nitric oxide in bacterial meningitis in children.
Kornelisse RF; Hoekman K; Visser JJ; Hop WC; Huijmans JG; van der Straaten PJ; van der Heijden AJ; Sukhai RN; Neijens HJ; de Groot R
J Infect Dis; 1996 Jul; 174(1):120-6. PubMed ID: 8655981
[TBL] [Abstract][Full Text] [Related]
5. Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity.
Drulović J; Dujmović I; Mesaros S; Samardzić T; Maksimović D; Stojsavljević N; Lević Z; Mostarica Stojokvić M
Mult Scler; 2001 Feb; 7(1):19-22. PubMed ID: 11321188
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis.
Danilov AI; Andersson M; Bavand N; Wiklund NP; Olsson T; Brundin L
J Neuroimmunol; 2003 Mar; 136(1-2):112-8. PubMed ID: 12620649
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide as an activity marker in multiple sclerosis.
Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients.
Miljkovic Dj; Drulovic J; Trajkovic V; Mesaros S; Dujmovic I; Maksimovic D; Samardzic T; Stojsavljevic N; Levic Z; Mostarica Stojkovic M
Eur J Neurol; 2002 Jul; 9(4):413-8. PubMed ID: 12099927
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course.
Svenningsson A; Petersson AS; Andersen O; Hansson GK
Neurology; 1999 Nov; 53(8):1880-2. PubMed ID: 10563648
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites in postoperative patients with subarachnoid hemorrhage.
Sadamitsu D; Kuroda Y; Nagamitsu T; Tsuruta R; Inoue T; Ueda T; Nakashima K; Ito H; Maekawa T
Crit Care Med; 2001 Jan; 29(1):77-9. PubMed ID: 11176164
[TBL] [Abstract][Full Text] [Related]
11. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
[TBL] [Abstract][Full Text] [Related]
12. Markedly elevated nitrate/nitrite levels in the cerebrospinal fluid of children with progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome).
Vanhatalo S; Riikonen R
Epilepsia; 2000 Jun; 41(6):705-8. PubMed ID: 10840402
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course.
Ramsaransing GS; Teelken A; Arutjunyan AV; De Keyser J
Neurology; 2004 Jan; 62(2):239-42. PubMed ID: 14745060
[TBL] [Abstract][Full Text] [Related]
14. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage.
Suzuki Y; Osuka K; Noda A; Tanazawa T; Takayasu M; Shibuya M; Yoshida J
Neurosurgery; 1997 Oct; 41(4):807-11; discussion 811-2. PubMed ID: 9316041
[TBL] [Abstract][Full Text] [Related]
16. Plasma nitrogen oxides and blood lactate concentrations in Ghanaian children with malaria.
Agbenyega T; Angus B; Bedu-Addo G; Baffoe-Bonnie B; Griffin G; Vallance P; Krishna S
Trans R Soc Trop Med Hyg; 1997; 91(3):298-302. PubMed ID: 9231201
[TBL] [Abstract][Full Text] [Related]
17. Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker.
Brundin L; Morcos E; Olsson T; Wiklund NP; Andersson M
Eur J Neurol; 1999 Sep; 6(5):585-90. PubMed ID: 10457392
[TBL] [Abstract][Full Text] [Related]
18. Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis.
Taskiran D; Sagduyu A; Yüceyar N; Kutay FZ; Pögün S
Int J Neurosci; 2000; 101(1-4):65-72. PubMed ID: 10765991
[TBL] [Abstract][Full Text] [Related]
19. Levels of nitric oxide metabolites in cerebrospinal fluid in cluster headache.
Steinberg A; Wiklund NP; Brundin L; Remahl AI
Cephalalgia; 2010 Jun; 30(6):696-702. PubMed ID: 20511209
[TBL] [Abstract][Full Text] [Related]
20. Increased cerebrospinal fluid nitrite and nitrate levels in patients with lumbar spondylosis.
Asahara H; Yokoi I; Tamada T; Kabuto H; Ogawab N; Mori A; Inoue H
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):77-83. PubMed ID: 8824933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
